European countries with small populations can obtain low prices for drugs: Lithuania as a case history
Authors:
- 1 June 2011
- journal article
- research article
- Published by Taylor & Francis in Expert Review of Pharmacoeconomics & Outcomes Research
- Vol. 11 (3) , 343-349
Abstract
(2011). European countries with small populations can obtain low prices for drugs: Lithuania as a case history. Expert Review of Pharmacoeconomics & Outcomes Research: Vol. 11, No. 3, pp. 343-349. doi: 10.1586/erp.11.24Keywords
This publication has 33 references indexed in Scilit:
- Policies to Enhance Prescribing Efficiency in Europe: Findings and Future ImplicationsFrontiers in Pharmacology, 2011
- Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implicationsExpert Review of Pharmacoeconomics & Outcomes Research, 2010
- Use of Generics—A Critical Cost Containment Measure for All Healthcare Professionals in Europe?Pharmaceuticals, 2010
- Initiatives to enhance the quality and efficiency of statin and PPI prescribing in the UK: impact and implicationsExpert Review of Pharmacoeconomics & Outcomes Research, 2010
- Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevanceExpert Review of Pharmacoeconomics & Outcomes Research, 2009
- Insight into recent reforms and initiatives in Austria: implications for key stakeholdersExpert Review of Pharmacoeconomics & Outcomes Research, 2008
- Balancing Big Pharma’s booksBMJ, 2008
- Having Your Cake and Eating ItPharmacoEconomics, 2008
- Society already achieves economic benefits from generic substitution but fails to do the same for therapeutic substitutionBritish Journal of Clinical Pharmacology, 2007
- How much will Herceptin really cost?BMJ, 2006